Meridian Bioscience, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding, Public
- Established
- 1977-01-01
- Employees
- 515
- Market Cap
- -
Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains
- Conditions
- Streptococcus Agalactiae Infection
- Interventions
- Device: Comparison between GenePOC PCR and Reference Method
- First Posted Date
- 2016-03-24
- Last Posted Date
- 2021-05-03
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 771
- Registration Number
- NCT02718157
- Locations
- 🇨🇦
Mount Sinai Hospital Joseph and Wolf Lebovic Health Complex, Toronto, Ontario, Canada
🇺🇸Tricore Laboratory University of New Mexico, Albuquerque, New Mexico, United States
🇺🇸Detroit Medical Center University Laboratories, Detroit, Michigan, United States
Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection
- Conditions
- Helicobacter Pylori Infection
- Interventions
- Device: Dual Mode BreathID Hp System
- First Posted Date
- 2015-08-19
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 282
- Registration Number
- NCT02528721
- Locations
- 🇺🇸
Del Sol Research Management, Tucson, Arizona, United States
🇺🇸Gasrtrenetrology Associates of Western Michigan, West Michigan Clinical Research Center, Wyoming, Michigan, United States
🇺🇸Ventura Clinical Trials, Ventura, California, United States
Detection of Mycoplasma Pneumoniae
- Conditions
- Mycoplasma Pneumoniae
- Interventions
- Device: illumigene® Mycoplasma Direct, illumipro-10
- First Posted Date
- 2015-07-30
- Last Posted Date
- 2016-02-08
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 471
- Registration Number
- NCT02511262
- Locations
- 🇺🇸
The Children's Mercy Hospital, Kansas City, Missouri, United States
🇺🇸Cook Children's Healthcare System (CCHCS), Ft. Worth, Texas, United States
🇺🇸Sacred Heart Health System, Pensacola, Florida, United States
BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH
- Conditions
- Non-Alcoholic Steatohepatitis
- Interventions
- Device: Suspected NASH BreathID test with 13C-OctanoateDevice: Suspected NASH Breath test with 13C Methacetin
- First Posted Date
- 2014-12-10
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT02314026
- Locations
- 🇬🇧
Freeman Hospital, New Castle, United Kingdom
🇺🇸Liver Associates, Houston, Texas, United States
🇺🇸Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
Equivalence of New Breath AnalyzerCompared to Currently BreathID System in Assessment of Liver Function
- Conditions
- Healthy VolunteersChronic Liver Disease (CLD)
- Interventions
- Device: MPBA SystemDevice: BreathID
- First Posted Date
- 2014-07-11
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02187601
- Locations
- 🇮🇱
Assaf Harofe Medical Center, Tzrifin, Israel
Assessing Portal Hypertension With Methacetin Breath Test
- Conditions
- Patients With Compensated Liver Cirrhosis
- Interventions
- Device: Methacetin Breath Test
- First Posted Date
- 2014-05-21
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 246
- Registration Number
- NCT02143778
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
🇨🇭Inselspital, Bern, Switzerland
🇺🇸VA Connecticut HealthCare System, New Haven, Connecticut, United States
Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation
- Conditions
- Chronic Liver Disease
- First Posted Date
- 2014-03-11
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 579
- Registration Number
- NCT02084160
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
🇺🇸Medical University of South Carolina, Charleston, South Carolina, United States
🇮🇱Hadassah Medical Origanzation, Jerusalem, Israel
Detection of Chlamydia (CT) and Gonorrhea (NG)
- Conditions
- GonorrheaChlamydia
- Interventions
- Device: illumigene CT and NG assays, illumipro-10
- First Posted Date
- 2014-02-05
- Last Posted Date
- 2017-12-07
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 700
- Registration Number
- NCT02055742
- Locations
- 🇺🇸
Planned Parenthood of the Rocky Mountains, Aurora, Colorado, United States
🇺🇸Planned Parenthood Southeastern PA, Philadelphia, Pennsylvania, United States
🇺🇸New England Center for Clinical Research, Fall River, Massachusetts, United States
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
- Conditions
- Helicobacter Pylori Infection
- Interventions
- Other: Breath Test Collection bags
- First Posted Date
- 2013-12-12
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 193
- Registration Number
- NCT02010112
- Locations
- 🇺🇸
Metropolitan Gastroenterology Group, Chevy Chase, Maryland, United States
🇺🇸Clinical Research Solutions, Jackson, Tennessee, United States
🇺🇸Digestive Disease Associates, PA, Baltimore, Maryland, United States
MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy
- Conditions
- Chronic Liver DiseaseBleedingCirrhosisEsophageal VaricesPortal Hypertension
- Interventions
- Device: Methacetin (with Breath testing device)
- First Posted Date
- 2013-05-10
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT01851252
- Locations
- 🇮🇱
Carmel Medical Center, Haifa, Israel